Diligence memo · auto-generated · as of July 2, 2026

Emovid Corp

Emovid Corp looks fair against its niche peers and is quiet on financing cadence.

SourceRaising on rhythm with a 2.2× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

Emovid Corp operates in Other Technology, based in SEATTLE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Emovid Corp has raised $6.2M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $6.2M on 2024-05-08.

Most recent recorded round closed around 2024-05-08.

Valuation (modeled)modeled

Provath models Emovid Corp at approximately $36M (range $8.3M–$81M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.72× the median modeled value of Series A Other Technology companies in 2022–2024 (1325 peers) — value vs value, same stage and era. Within the normal band (72% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 2.1 yr ago; this sector typically re-raises about every 13 months.

Slightly overdue versus sector cadence.

Comparablesmixed

Capital scale ranks ahead of 63% of Other Technology peers (21302 compared).

Modeled value ranks above 49% of those peers.

Closest niche peers: Phylum, Inc., Keon Foundation Ltd., Remoteam Inc., MultiSafe, Inc., Careerian Inc..

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.